NBC Securities’s iShares Biotechnology ETF IBB Stock Holding History

NBC Securities’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$569K	Sell	2,994 -43	-1%	-$7.39K	0.04%	483
2026 Q1	$513K	Sell	3,037 -5	-0.2%	-$855	0.04%	497
2025 Q4	$513K	Sell	3,042 -59	-2%	-$9.58K	0.04%	494
2025 Q3	$448K	Sell	3,101 -205	-6%	-$28K	0.03%	544
2025 Q2	$418K	Sell	3,306 -478	-13%	-$58.7K	0.03%	555
2025 Q1	$483K	Buy	3,784 +3,780	+94,500%	+$513K	0.04%	467
2024 Q4	$579	Sell	4 -4,597	-100%	-$646K	0.05%	400
2024 Q3	$669K	Buy	4,601 +3	+0.1%	+$434	0.06%	367
2024 Q2	$631K	Sell	4,598 -206	-4%	-$27.5K	0.06%	358
2024 Q1	$659K	Sell	4,804 -143	-3%	-$19.5K	0.06%	359
2023 Q4	$672K	Sell	4,947 -190	-4%	-$23.2K	0.07%	314
2023 Q3	$628K	Buy	+5,137	New	+$653K	0.07%	311

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

NBC Securities's IBB Position: Q2 2026 in Review

NBC Securities reduced its iShares Biotechnology ETF (IBB) stake by 1.4% in Q2 2026, selling an estimated $7.39K and leaving 2,994 shares worth $569K. The position accounts for 0.04% of the portfolio, ranked #483.

NBC Securities first reported a position in IBB in Q3 2023 and has held it in 12 quarters since. The position peaked at $672K in Q4 2023. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

NBC Securities held 2,994 shares of iShares Biotechnology ETF worth $569K as of Q2 2026.
NBC Securities sold 43 iShares Biotechnology ETF shares in Q2 2026, an estimated $7.39K.
iShares Biotechnology ETF made up 0.04% of NBC Securities's portfolio in Q2 2026, its #483 holding.
NBC Securities first reported a position in iShares Biotechnology ETF in Q3 2023 and has held it in 12 quarters since.
NBC Securities's iShares Biotechnology ETF position peaked at $672K in Q4 2023.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.